vidal_kathi_sv_color_cropped-2-
5 September 2022PatentsMuireann Bolger

Fintiv-based PTAB decision faces scrutiny from Vidal

USPTO director’s decision to step in puts more spotlight on controversial rule | Vidal uses remit granted by US v Arthrex.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Patents
23 November 2022   Kathi Vidal’s explosive intervention in OpenSky v VLSI saw dormant concerns over the director review process resurface. Did she go too far, will she change tack, and what might a new-look process look like? Muireann Bolger speaks to lawyers from Wilson Sonsini Goodrich & Rosati, Haynes Boone, and Finnegan to find out more.
Patents
8 December 2022   With the addition of USPTO director reviews and some key cases, the Patent Trial and Appeal Board has once again had a remarkable year, finds Muireann Bolger.
Patents
18 October 2022   USPTO director agrees to consider the Board's decision, citing the ‘unusual and complex nature’ of the case | Vidal announces review after sanctioning OpenSky for alleged IPR abuse.